Drug · DIN 00828564
TEVA-RANITIDINE
FILM-COATED
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 22, 2018; first marketed December 31, 1989.
- Drug Identification Number (DIN)
- 00828564
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ranitidine A02BA02
- Class
- Human
- Record last updated
- July 28, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RANITIDINE (RANITIDINE HYDROCHLORIDE) | 150 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 24, 2011: NOC 12027New Drug Submission (NDS) · Manufacturer and product name change
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “teva-ranitidine”. A notice may cover another product or only some lots: read it to see what it covers.
- Teva-Ranitidine (2016-06-09)June 17, 2016 · Drugs · Product safety · Type II
Other DINs named TEVA-RANITIDINE
- DIN 00828556 · Cancelled Post Market